OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future
Seung‐Hwan Lee, Kun‐Ho Yoon
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 5, pp. 629-640
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Konjac Glucomannan: An Emerging Specialty Medical Food to Aid in the Treatment of Type 2 Diabetes Mellitus
Yimeng Fang, Jiahui Ma, Pengyu Lei, et al.
Foods (2023) Vol. 12, Iss. 2, pp. 363-363
Open Access | Times Cited: 25

Glucose-Responsive Silk Fibroin Microneedles for Transdermal Delivery of Insulin
Guohongfang Tan, Fujian Jiang, Tianshuo Jia, et al.
Biomimetics (2023) Vol. 8, Iss. 1, pp. 50-50
Open Access | Times Cited: 12

Oral delivery of protein and peptide therapeutics
Vivek P. Chavda, Pankti C. Balar
Progress in molecular biology and translational science (2025), pp. 355-387
Closed Access

Development and validation of a Chinese insulin medication literacy scale for patients with diabetes mellitus
Fengzhi Si, Tao Feng, Xiangfen Shi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Thiamine and METTL14 in Diabetes Management with Intensive Insulin Therapy
Miaoguan Peng, Yingying Zhang, Xiaoshi Weng, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 980-980
Open Access

In Vitro BioTransformation (ivBT): Definitions, Opportunities, and Challenges
Y.‐H. Percival Zhang, Zhiguang Zhu, Chun You, et al.
Synthetic biology and engineering (2023) Vol. 1, Iss. 2, pp. 1-37
Open Access | Times Cited: 9

Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data
Andrew Mulcahy, Daniel Schwam
RAND Corporation eBooks (2024)
Open Access | Times Cited: 3

A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein
Jiaqi Lü, Kam‐Bo Wong, Pang‐Chui Shaw
Toxins (2022) Vol. 14, Iss. 3, pp. 178-178
Open Access | Times Cited: 14

Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
Ruyu Shi, Dongxue Chen, Mingyue Ji, et al.
Food Science and Human Wellness (2023) Vol. 12, Iss. 6, pp. 2001-2013
Open Access | Times Cited: 8

Antidiabetic Potential of Phytochemicals Found in Vernonia amygdalina
Archna Talwar, Neha Chakraborty, Manaal Zahera, et al.
Journal of Chemistry (2024) Vol. 2024, pp. 1-12
Open Access | Times Cited: 2

Muco-Adhesive and Muco-Penetrative Formulations for the Oral Delivery of Insulin
Srijita Paul, Snigdha Bhuyan, Divya Dharshni Balasoupramanien, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 24121-24141
Open Access | Times Cited: 2

Insulin’s Legacy: A Century of Breakthroughs and Innovation
Somar Hadid, Emily Zhang, William H. Frishman, et al.
Cardiology in Review (2024)
Closed Access | Times Cited: 1

Investigation on Quality Characteristics and Antidiabetic Properties of Mulberry Leaf Fu Brick Tea
Yuanyuan Shao, Ling Lin, Wei Xu, et al.
Journal of Food Biochemistry (2024) Vol. 2024, pp. 1-15
Open Access | Times Cited: 1

Prandial Insulins: A Person-Centered Choice
Bhawna Attri, Lakshmi Nagendra, Deep Dutta, et al.
Current Diabetes Reports (2024) Vol. 24, Iss. 6, pp. 131-145
Closed Access | Times Cited: 1

TRPV1: a novel target for the therapy of diabetes and diabetic complications
Yu-Rong Shen, Long Cheng, Dongfang Zhang
European Journal of Pharmacology (2024), pp. 177021-177021
Closed Access | Times Cited: 1

Heyndrickxia coagulans spore-based nanoparticle generator for improved oral insulin delivery and hypoglycemic therapy
Juan Liang, Mengxin Bai, Yan-long Bi, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 103-115
Closed Access | Times Cited: 1

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
Sofie Broeng-Mikkelgaard, Julie Maria Bøggild Brøsen, Peter Lommer Kristensen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3

Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
Eun‐Jung Rhee
Endocrinology and Metabolism (2022) Vol. 37, Iss. 3, pp. 415-429
Open Access | Times Cited: 3

Automated insulin delivery systems in elderly patients with brittle type 2 diabetes
Özge Telci Çaklılı, Ferhat Cetin, Melike Ozkan, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111913-111913
Closed Access

PEPTIDOLOGY, PEPTIDOMICS AND PEPTIDE MEDICINE — HISTORY AND PERSPECTIVES
Yuri Bykov, Roman Aleksandrovich Bekker, Mikhaïl Grigoriev
Publishing Center RIOR eBooks (2024)
Closed Access

The Role of Cellular Agriculture in Mitigating Climate Change
Ahmed Hamad, Dina A. B. Awad
Advances in environmental engineering and green technologies book series (2024), pp. 255-287
Closed Access

Early use of SGLT2 inhibitors reduces the progression of diabetic kidney disease: a retrospective cohort study
Shaowei Pang, Xiaoli Li
American Journal of Translational Research (2024) Vol. 16, Iss. 9, pp. 4967-4978
Closed Access

Page 1 - Next Page

Scroll to top